Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jan Kluytmans"'
Autor:
Christina M. J. E. Vandenbroucke-Grauls, Martine C. Rijnsburger, James R. Johnson, Jan Kluytmans, David M. Gordon, Ina Willemsen, I. T. M. A. Overdevest, Paul H. M. Savelkoul, Max Heck, Marjolein F. Q. Kluytmans-van den Bergh, Brian D. Johnston, Kim van der Zwaluw
Publikováno v:
Kluijtmans, J A J W, Overdevest, I T M A, Willemsen, I, Kluytmans-van den Bergh, M, van der Zwaluw, K, van Heck, M, Rijnsburger, M, Vandenbroucke-Grauls, C M J E, Savelkoul, P H M, Johnston, B D, Gordon, D & Johnson, J R 2013, ' Extended-Spectrum beta-Lactamase-Producing Escherichia coli From Retail Chicken Meat and Humans: Comparison of Strains, Plasmids, Resistance Genes, and Virulence Factors ', Clinical Infectious Diseases, vol. 56, no. 4, pp. 478-487 . https://doi.org/10.1093/cid/cis929
Clinical Infectious Diseases, 56(4), 478-487. Oxford University Press
Clinical Infectious Diseases, 56(4), 478-487. Oxford University Press
BACKGROUND: The worldwide prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is increasing rapidly both in hospitals and in the community. A connection between ESBL-producing bacteria in food animals, retail meat, and
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 55(11)
The study by Tschudin-Sutter and colleagues from Basel, Switzerland, in this issue ofClinical Infectious Diseases[1] questions the added value of contact precautions compared with standard precautions to prevent the spread of extended-spectrum beta-l
Autor:
Jan Kluytmans, Boulos Maraha, Marcel F. Peeters, Christina M. J. E. Vandenbroucke-Grauls, Michael Quarles-van Ufford, Gert Jan Scheffer, Hans F. Berg
Publikováno v:
Clinical Infectious Diseases, 40(3), 358-365. Oxford University Press
Clinical Infectious Diseases, 40, 3, pp. 358-65
Clinical infectious diseases, 40(3), 358-365. Oxford University Press
Clinical Infectious Diseases, 40, 358-65
Berg, H F, Maraha, B, Scheffer, G J, Quarles-van Ufford, M, Vandenbroucke-Grauls, C M J E, Peeters, M F & Kluytmans, J A 2005, ' Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events ', Clinical Infectious Diseases, vol. 40, no. 3, pp. 358-365 . https://doi.org/10.1086/427111
Clinical Infectious Diseases, 40, 3, pp. 358-65
Clinical infectious diseases, 40(3), 358-365. Oxford University Press
Clinical Infectious Diseases, 40, 358-65
Berg, H F, Maraha, B, Scheffer, G J, Quarles-van Ufford, M, Vandenbroucke-Grauls, C M J E, Peeters, M F & Kluytmans, J A 2005, ' Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events ', Clinical Infectious Diseases, vol. 40, no. 3, pp. 358-365 . https://doi.org/10.1086/427111
Item does not contain fulltext BACKGROUND: Recently, it has been suggested that Chlamydia pneumoniae possibly plays a possible role in the pathogenesis of atherosclerosis. We investigated whether treatment with clarithromycin prior to coronary artery